KARYOPHARM THERAPEUTICS INC shareholders Q3 2023

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
Parkwood LLC 1,000,000$6610.07%
XTX Topco Ltd 310,065$415,4870.07%
GSA CAPITAL PARTNERS LLP 568,298$7620.06%
Ikarian Capital, LLC 400,000$536,0010.06%
Atom Investors LP 190,825$255,7060.06%
Redwood Wealth Management Group, LLC 32,730$43,8580.05%
UBS OCONNOR LLC 876,710$1,174,7910.03%
KENNEDY INVESTMENT GROUP 35,000$46,9000.03%
C WorldWide Group Holding A/S 1,500,000$2,0100.03%
ELCO Management Co., LLC 22,561$30,2320.02%
External links

This page lists KARYOPHARM THERAPEUTICS INC's shareholders in Q3 2023. To view KARYOPHARM THERAPEUTICS INC's shareholder history, click here.